1996
DOI: 10.1590/s0037-86821996000100009
|View full text |Cite
|
Sign up to set email alerts
|

Treatment of T. cruzi infected human platelet concentrates with aminomethyltrimethyl psoralen (AMT) and ultravioleta (UV-A) light: preliminary results

Abstract: lh e present measures adopted to prevent transfusion-associated Chagas' disease include screening o f blood donors. ancl/or the inactivation q/'T. cruzi in collected blood using gentian violet (GV). as a tiypanocidal agent. ín this study, ive investigated the efficacy of the com biued use o f AM T a n d UV-A in inactirating T. cruzi in infected h u m a n platelet cuncentrates. H um an platelet concentrates were infected u ith T. cruzi (2x1 (T7ml) o f the Y strain. transfered to PL 269 (Fenwal Laboratories) con… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

1996
1996
2017
2017

Publication Types

Select...
2
2

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(1 citation statement)
references
References 6 publications
0
1
0
Order By: Relevance
“…The described inactivation protocol therefore will eliminate infectivity in a 50 mL unit of PC. The observation that the trypomastigote motility is more resistant to PUVA treatment than loss of infectivity explains an earlier report that AMT is ineffective as a parasite-inactivating reagent (15). In that report, viability of parasites was evaluated using motility 24 h after treatment as an endpoint.…”
Section: Discussionmentioning
confidence: 97%
“…The described inactivation protocol therefore will eliminate infectivity in a 50 mL unit of PC. The observation that the trypomastigote motility is more resistant to PUVA treatment than loss of infectivity explains an earlier report that AMT is ineffective as a parasite-inactivating reagent (15). In that report, viability of parasites was evaluated using motility 24 h after treatment as an endpoint.…”
Section: Discussionmentioning
confidence: 97%